Summary
Based on the information provided, the following summarized findings regarding FDa regulations for electronic nicotine delivery systems (ENDS) and tobacco products can be highlighted:
1. The FDa has regulatory authority over ENDS and tobacco products, as outlined in the "Vaporizers, E-Cigarettes, and Other Electronic Nicotine Delivery Systems (ENDS)" section of their website (accessed on 1 September 2022).
2. a systematic review by hod, Nor, and Manjam (2022) explored the effects of e-cigarettes on weight gain and adipocytes, but it did not specifically delve into FDa regulations.
3. Glasser et al. (2019) conducted a review on patterns of e-cigarette use among youth and young adults and its impact on cigarette smoking, but they did not focus on FDa regulations.
4. Merrill et al. (2016) provided an overview of the FDa's regulation of electronic nicotine delivery systems and tobacco products in the Journal of Oncology Practice, emphasizing that the FDa's regulations cover ENDS, cigars, hookah tobacco, pipe tobacco, and roll-your-own tobacco.
5. The Korean Law Information Center also offers information on electronic cigarettes and related regulations in Korea (accessed on 1 September 2022), but this source does not provide specific findings on FDa regulations.
In summary, the key findings revolve around the FDa's regulatory authority over ENDS and tobacco products, including e-cigarettes. The provided sources discuss various aspects of e-cigarette use and related health effects, as well as regulations in other countries, but they do not offer specific findings on FDa regulations beyond the overview by Merrill et al. (2016).
Citation
Kim J, Lee S, Chun J. an International Systematic Review of Prevalence, Risk, and Protective Factors associated with Young People’s E-Cigarette Use. International journal of environmental research and public health. 2022;19(18). doi:10.3390/ijerph191811570
